Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.
about
Glycoproteins and glycoproteomics in pancreatic cancerFrom synthesis to biologics: preclinical data on a chemistry derived anticancer vaccineOn the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.Anti-cancer properties of gastropodan hemocyanins in murine model of colon carcinoma.ABH and Lewis histo-blood group antigens in cancer.Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in miceCancer vaccines and carbohydrate epitopes.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Active immunization with human interleukin-15 induces neutralizing antibodies in non-human primates.Immunotherapy in ovarian cancer.A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First RemissionBiologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinicA new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.Recent Departures in the Synthesis of Peptides and Glycopeptides.Immunotherapy for cancer: synthetic carbohydrate-based vaccines.Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines."Biologic" level structures through chemistry: A total synthesis of a unimolecular pentavalent MUCI glycopeptide construct.Cancer Vaccines in Ovarian Cancer: How Can We Improve?Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
P2860
Q28071108-02345C20-603C-4B11-93CE-94600F4AD89BQ33466255-B78336CE-306E-4B7E-97A9-804D9F496DC3Q34160588-FDAEBFD9-456B-4EF7-802E-72B0D56CCE72Q34184980-B85D82B6-DF78-44AA-8761-6ECDD903994AQ34215529-AD9C3BD7-35F1-49EB-8793-75C484A341E4Q34719681-B9D39014-E7C3-48D4-B817-BDB8571DCB37Q35525289-0AFF6B9E-68EC-4D11-85DC-3FC4867CF24BQ35854131-58F3E533-CA74-4AE9-8D74-ABD9E1BE7D37Q36145575-A9D0A4F8-3B4A-441D-B9EC-1954AA96335FQ36631249-06F8D850-B862-4F4D-9DBE-2A109EDA4153Q36841027-15C516CE-0C2E-4AB8-9E74-FAC4603AFC0DQ37186518-7467C55C-E45E-4760-AFE4-FF84BBA9ED9FQ37303845-8A7AF99D-070C-4996-A4C0-9D52E1FE1018Q37380026-3BC06C62-11DC-4466-9FD1-EB40D331A56AQ37428099-16309246-B37D-4468-8BEE-1D7464505B85Q37453814-C7582AA0-C287-4AA7-B801-DD0A398BA9DDQ37484024-16383453-DFA6-4F7A-A654-A1A6B35E3949Q37608314-3D20096F-722B-49E2-A6C4-282907391295Q37974938-FD2A0494-5305-4C2C-924C-51E1DEF17155Q38544783-11917412-A18B-4A19-A669-26AABDF9C162Q41965469-655AF7A4-95F2-49CB-906F-70BE0C457923Q42032234-68ABC3E6-CAA0-413A-AFED-DC2EA0F71BF2Q54385315-FA176174-2F5B-457D-84AF-2FC67EC51F1CQ54993659-0059759A-A5E7-4D17-AF28-E7DB991F6D8B
P2860
Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Immunization of ovarian cancer ...... gate vaccine: a phase 1 trial.
@en
type
label
Immunization of ovarian cancer ...... gate vaccine: a phase 1 trial.
@en
prefLabel
Immunization of ovarian cancer ...... gate vaccine: a phase 1 trial.
@en
P2093
P921
P1476
Immunization of ovarian cancer ...... gate vaccine: a phase 1 trial.
@en
P2093
A Zatorski
C Aghajanian
C O'Flaherty
G Ragupathi
M Spassova
P J Sabbatini
P356
10.1002/1097-0215(20000701)87:1<79::AID-IJC12>3.3.CO;2-C
P577
2000-07-01T00:00:00Z